During this one-hour webinar, expert analysts will share insights on recently amended regulatory developments across the Americas in 2024 so far, plus look at what’s coming up. Join on Wednesday 4 September by clicking here.
Ben KempAugust 27, 2024
MedTech Europe have submitted the attached information, to the EU consultation (Persistent organic pollutants - UV-328 (europa.eu)) on inclusion of UV-328 under the Stockholm Convention on Persistent Organic Pollutants. UV-328 is a UV blocker commonly used to prevent degradation of materials such as plastics. The UK is also a signatory to the Convention, So I’m sharing the MedTech Europe response…
Ben KempAugust 27, 2024
A GB MCL Agency Opinion formally proposes the GB mandatory classification and labelling for chemical substances, based on the scientific and technical assessment of the scientific data in line with the GB CLP Regulation, together with an assessment of the policy and socio-economic impacts on the UK. It sets out whether there is adequate scientific evidence to support a new…
Ben KempAugust 27, 2024
Reminder – upcoming EU active substance open invitation deadlines Submit a notification by the deadline to keep active substances in the EU Review Programme The European Chemicals Agency (ECHA) has published open invitations to provide an opportunity for a person, company or task force/consortium to notify an intention to take up or take over the role of participant in the…
Ben KempAugust 27, 2024
You can find the latest ECHA consultations here, including: two new consultations on harmonised classification and labelling proposals for: 4-hydroxy-4-methylpentan-2-one; diacetone alcohol (EC 204-626-7, CAS 123-42-2); and 8-methyldecan-2-yl propionate; 8-methyldecan-2-yl propanoate (EC -, CAS 81931-28-4).
Ben KempAugust 27, 2024
TBI – Prosperity Through Health: The Macroeconomic Case for Investing in Preventative Health Care in the UK TBI’s report advocating for greater action on prevention of ill health estimates that a 20 per cent reduction in the incidence of six major disease categories that are keeping people out of work – cancer, cardiovascular disease (CVD), chronic respiratory illness, diabetes and…
Ben KempAugust 27, 2024
A reminder that registration is open for Cardiac Marker Dialogues 2024: Cardiac Biomarkers in Real Time - experiences and opportunities. Make sure to book by Friday 30 August to take advantage of the early bird rate. Hosted by UK NEQAS Cardiac Markers, Cardiac Marker Dialogues: Cardiac Biomarkers in Real Time - experiences and opportunities will be held in Glasgow on…
Ben KempAugust 27, 2024
The Tony Blair Institute for Global Change (TBI) has developed a tool which can map where data is generated across the UK’s health system, helping to guide efficiencies and uncover areas for discussion and development. The organisation has long called for improved utilisation of health data to make the NHS a more efficient and dynamic health service. The full data-architecture…
Ben KempAugust 27, 2024
BIVDA's Paul Fisher supported an Innovate UK Trade Mission workshop, which focussed on AMR diagnostics and therapeutics. Throughout 2024, Innovate UK have hosted their Global Business Innovation Programme for Antimicrobial Resistance. This initiative is aimed at businesses that focus on diagnostics and therapeutics within the area of AMR. The programme consisted of three phases; a “Get Ready” workshop, a one-week…
Ben KempAugust 27, 2024
The European Commission has suggested revising the common specifications for certain class D in vitro diagnostic devices to address tests for specific parasites and viruses of public health importance. Stakeholders have a four-week period to provide feedback on these proposed changes. On 19 August, the Commission released the proposed amendments, which, if approved, would update the In Vitro Diagnostic Medical…
Ben KempAugust 27, 2024